EZZ has achieved a significant milestone after being reclassified on the ASX as the genome-specialist looks to broaden its market share in the biotech and life sciences sector. Aussie-listed genomic-tech firm, EZZ Life Science Holdings (ASX:EZZ) has had its listing…

Speakers including Luis Vitetta, Clinical Prof. with @Sydney_Uni, Gemma Acton, Network Finance Manager @7NewsSydney and Glenn Cross, EZZ Life Science Chairman.